INM
$1.68
Inmed Pharmaceuticals
($.01)
(.59%)
INM
Earnings Whisper ®
N/A
2nd Quarter December 2021
Consensus:  ($0.23)
Revenue:  $0.50 Mil
Wednesday
Feb 9
7:30 AM ET
Score
Grade
Tweet Share Watch
Tweet Share Watch

What do you expect when INM reports earnings?
Beat
Meet
Miss

Where is INM's stock price going from here?
Up
Flat
Down
Stock chart of INM
Analysts
Summary of analysts' recommendations for INM
Score
Grade
Pivots
Resistance
$1.87
$1.79
$1.74

$1.66

Support
$1.61
$1.53
$1.48
Tweet
Growth
Description
InMed Pharmaceuticals Inc. is a clinical-stage pharmaceutical company. It engages in developing a pipeline of cannabinoid-based medications, initially focused on the therapeutic benefits of cannabinol in diseases with unmet medical need. InMed Pharmaceuticals Inc. is based in VANCOUVER, BC.